Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about ACAD
Recent news which mentions ACAD
< Previous
1
2
3
4
5
6
Next >
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
September 12, 2022
Tickers
ACAD
ADMP
AGEN
ALEC
Tags
ALEC
ACAD
General
From
Benzinga
U.S. FDA Accepts Acadia's Filing For Rett Syndrome Candidate Under Priority Review
September 12, 2022
Tickers
ACAD
Tags
News
ACAD
General
From
Benzinga
Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know
August 31, 2022
Tickers
ACAD
AMGN
AMLX
AXSM
Tags
AXSM
Top Stories
AMLX
From
Benzinga
ACADIA Pharmaceuticals's Return On Capital Employed Insights
August 29, 2022
Tickers
ACAD
Tags
ACAD
Benzinga
Earnings
From
Benzinga
Acadia Terminates Painkiller, Cancer Candidate After Disappointing Data
August 09, 2022
Tickers
ACAD
VRTX
Tags
Briefs
News
Biotech
From
Benzinga
ACADIA Pharmaceuticals Faces Several Price Target Cuts After Q2 Results, But This Analyst Disagrees
August 09, 2022
Tickers
ACAD
Tags
News
Pre/Market Outlook
Price Target
From
Benzinga
NVIDIA To $240? Here Are 5 Other Price Target Changes For Tuesday
August 09, 2022
Tickers
ACAD
BC
CRSP
MNDY
Tags
CRSP
Market News
TNDM
From
Benzinga
ACADIA Pharmaceuticals: Q2 Earnings Insights
August 08, 2022
Tickers
ACAD
Tags
ACAD
Benzinga
Market News
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022
August 08, 2022
Tickers
ACAD
AZEK
BALL
BCRX
Tags
ITRI
MAIN
LEU
From
Benzinga
8 Analysts Have This to Say About ACADIA Pharmaceuticals
August 05, 2022
Tickers
ACAD
Tags
Benzinga
ACAD
BZI/AAR
From
Benzinga
Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases
August 05, 2022
Tickers
ACAD
AKBA
ALDX
AMRX
Tags
Movers
MYOV
News
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022
August 05, 2022
Tickers
AAWW
ACAD
ARRY
ATI
Tags
PARA
DCPH
BZI/Ratings
From
Benzinga
Benzinga Before The Bell: Should Investors Worry About Tesla's China Sales, Gold Back In Focus, Nio Smartphone Could Soon Be A Reality Other Top Financial Stories Friday, August 5
August 05, 2022
Tickers
AAPL
ACAD
COIN
INTC
Tags
SPCE
COIN
META
From
Benzinga
FDA Asks For Additional Study For Acadia's Pimavanserin In Alzheimer's-Associated Delusions
August 05, 2022
Tickers
ACAD
Tags
ACAD
General
Health Care
From
Benzinga
Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate
August 04, 2022
Tickers
ABUS
ACAD
ADAP
AGIO
Tags
Biotech
Small Cap
Offerings
From
Benzinga
Biotech Investors: August's Key PDUFA Catalysts You Must Know
July 31, 2022
Tickers
ACAD
AMGN
AXSM
BGNE
Tags
INCY
ACAD
General
From
Benzinga
The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings
July 19, 2022
Tickers
ACAD
APLS
AVDL
AZN
Tags
General
CELC
ACAD
From
Benzinga
Recap of Monday's Biotech Catalysts - End of the Day Summary
July 18, 2022
Tickers
ABBV
ACAD
ACER
APYX
Tags
Penny Stocks
ACER
ETON
From
Benzinga
Acadia Seeks FDA Approval For Genetic Neurological Disorder Candidate
July 18, 2022
Tickers
ACAD
Tags
NDA Filing
FDA
Benzinga
From
Benzinga
Where ACADIA Pharmaceuticals Stands With Analysts
July 11, 2022
Tickers
ACAD
Tags
BZI/AAR
ACAD
Benzinga
From
Benzinga
67 Biggest Movers From Yesterday
June 22, 2022
Tickers
ACAD
ACER
ALV
AMED
Tags
REV
GRNQ
CNVY
From
Benzinga
Analysts Try To See Beyond Acadia's Alzheimer's Disease Psychosis
June 21, 2022
Tickers
ACAD
Tags
Analyst Color
Market News
Analyst Ratings
From
Benzinga
Why Is Acadia Pharmaceuticals (ACAD) Stock Down 33% Today?
June 21, 2022
Tickers
ACAD
Tags
Market News
NASDAQ:ACAD
Today's Market
From
InvestorPlace
Nasdaq Rises 2.5%; ACADIA Pharmaceuticals Shares Plummet
June 21, 2022
Tickers
ACAD
BHAT
BPT
CNVY
Tags
ODP
Markets
Homebuilding
From
Benzinga
Dow Jumps 550 Points; Convey Health Solutions Shares Spike Higher
June 21, 2022
Tickers
ACAD
ARVL
BHAT
CNVY
Tags
Commodities
News
Eurozone
From
Benzinga
Why Acadia Pharmaceuticals Stock Is Crashing Today
June 21, 2022
Tickers
ACAD
Tags
ACAD
Recent Press Releases
Market News
From
Motley Fool
45 Stocks Moving In Tuesday's Mid-Day Session
June 21, 2022
Tickers
ACAD
ALV
AMED
ARBK
Tags
HNRG
CASI
PRT
From
Benzinga
U.S. Markets Open Higher; Lennar Earnings Top Views
June 21, 2022
Tickers
ACAD
BKSY
CHWY
CNVY
Tags
Benzinga
Global
Penny Stocks
From
Benzinga
The Daily Biotech Pulse: Thumbs Down For Acadia's Pimavanserin, Pfizer Buys Stake In Valneva, AstraZeneca - Ionis Eplontersen Aces Rare Disease Trial
June 21, 2022
Tickers
ACAD
ACST
AURA
AZN
Tags
IBB
Movers
RXRX
From
Benzinga
Why Acadia Pharma Shares Are Plunging Today
June 21, 2022
Tickers
ACAD
Tags
Trading Ideas
FDA
Benzinga
From
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.